Comparing and combining TSPO-PET tracers in tauopathies

The pipeline was effective at harmonising TSPO-PET tracers and standardising the regional quantification of neuroinflammation in clinically matched cohorts of PSP, while the standardisation pipeline results were less robust across AD cohorts.

Authors

Institutions

Publication Details

Journal
European Journal of Nuclear Medicine and Molecular Imaging
Published
2025-10-20
DOI
https://doi.org/10.1007/s00259-025-07579-3
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparing and combining TSPO-PET tracers in tauopathies

Alexandra T. Strauss, Maura Malpetti, Tim D. Fryer, Robert Perneczky et al.
European Journal of Nuclear Medicine and Molecular Imaging
Alzheimer's disease research and treatments
article

Comparing and combining TSPO-PET tracers in tauopathies

Alexandra T. Strauss, Maura Malpetti, Tim D. Fryer, Robert Perneczky, John T. O’Brien, James Benedict Rowe, Boris‐Stephan Rauchmann, Gassan Massarweh, Johannes Levin, Carla Palleis, Nesrine Rahmouni, Johannes Gnörich, Franklin I. Aigbirhio, Günter U. Höglinger, Robert Hopewell, Nicolai Franzmeier, Pedro Rosa‐Neto, Matthias Brendel, Young T. Hong, P Simon Jones, Sebastian N. Roemer‐Cassiano
article en

Abstract

The pipeline was effective at harmonising TSPO-PET tracers and standardising the regional quantification of neuroinflammation in clinically matched cohorts of PSP, while the standardisation pipeline results were less robust across AD cohorts.

European Journal of Nuclear Medicine and Molecular ImagingVol. 53(3)
Montreal Neurological Institute and Hospital (CA), MRC Cognition and Brain Sciences Unit (GB), University of Cambridge (GB), German Center for Neurodegenerative Diseases (DE), Cambridge University Hospitals NHS Foundation Trust (GB), LMU Klinikum (DE), Cambridge School (PT), Southwestern Medical Center (US), Munich Cluster for Systems Neurology (DE), UK Dementia Research Institute (GB), Max Planck Institute for Human Cognitive and Brain Sciences (DE), Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal (CA), Imperial College London (GB), McGill University (CA), Ludwig-Maximilians-Universität München (DE), The University of Texas Southwestern Medical Center (US), University of Gothenburg (SE), University of Sheffield (GB)
Biogen, McGill University, TauRx Pharmaceuticals, Guarantors of Brain, Eisai, Novo Nordisk, Ludwig-Maximilians-Universität München, UK Dementia Research Institute
Openalex Percentile: Top 63%
Alzheimer's disease research and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.